LEADERMED
offers
A global pharmaceutical platform encompassing critical aspects of drug development.
IP creation, clinical efficacy testing, regulatory approval, manufacturing, marketing, sales and distribution.
A pipeline filled with potential new medications, including a new treatment for diabetes, to be offered in China and the Asia-Pacific region.
A FASTER PIPELINE
The LeaderMed team’s expertise allows them to advance and obtain regulatory approvals for new drugs in international markets outside the U.S. and Europe faster than what can be secured in those regions.
In the international markets our team members have led over 60 trials for innovative drugs; co-founded a CRO; led over 10 successful NDAs; and commercialized over $3 billion in global drug sales and medical devices, benefitting patients in over 50 countries.
What we believe

